ConceptioArchiveClinicalTrials.gov
ClinicalTrials.govpublic full text

The Efficacy and Safety of Rilzabrutinib in Participants Aged 10 to 65 Years With Sickle-cell Disease

Sanofi · 2025
ClinicalTrials.gov · Datasets · License: Public Domain · 2025
Open Source ↗
sickle-cell-disease
sickle cell disease, interventional, phase3
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 1010900
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.